Florian Scherer
Albert-Ludwigs-Universität Freiburg
H-index: 23
Europe-Germany
Top articles of Florian Scherer
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas | Neuro-oncology | Eliza M Lauer Ella Riegler Jurik A Mutter Stefan K Alig Sabine Bleul | 2024/2/1 |
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: a RANO review | Lakshmi Nayak Chetan Bettegowda Florian Scherer Norbert Galldiks Manmeet Ahluwalia | 2024/4/10 | |
High-dose chemotherapy and autologous haematopoietic stem-cell transplantation in older, fit patients with primary diffuse large B-cell CNS lymphoma (MARTA): a single-arm … | The Lancet Haematology | Elisabeth Schorb Lisa Kristina Isbell Andrea Kerkhoff Stephan Mathas Friederike Braulke | 2024/3/1 |
Circulating tumor DNA profiling for detection, risk stratification, and classification of brain lymphomas | Journal of Clinical Oncology | Jurik A Mutter Stefan K Alig Mohammad S Esfahani Eliza M Lauer Jan Mitschke | 2023/3/20 |
A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell … | Blood | Konstantinos Christofyllakis Viola Poeschel Bettina Altmann Stephanie Maurer Vadim Lesan | 2023/11/28 |
Development of highly sensitive digital droplet PCR for detection of CKIT mutations in circulating free DNA that mediate resistance to TKI treatment for Gastrointestinal … | International journal of molecular sciences | Michael Rassner Silvia Waldeck Marie Follo Stefanie Jilg Ulrike Philipp | 2023/3/12 |
Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS … | BMC cancer | Lisa K Isbell Roswitha Uibeleisen Alexander Friedl Elvira Burger Tatja Dopatka | 2023/8/18 |
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure | Blood Cancer Journal | Miriam Mozaffari Jovein Gabriele Ihorst Jesús Duque-Afonso Ralph Wäsch Hartmut Bertz | 2023/12/10 |
Clinical applications of circulating tumor DNA in central nervous system lymphoma | Anna Katharina Foerster Eliza M Lauer Florian Scherer | 2023/7/4 | |
Longitudinal Noninvasive Surveillance & Fragmentomic Characterization of Follicular Lymphoma | Blood | Joseph Schroers-Martin Jurik A Mutter Mohammad Shahrokh Esfahani Florian Scherer Joanne Soo | 2023/11/28 |
Tracing founder mutations in circulating and tissue-resident follicular lymphoma precursors | Cancer discovery | Joseph G Schroers-Martin Joanne Soo Gabriel Brisou Florian Scherer David M Kurtz | 2023/6/2 |
Long-Term Follow-up of AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation after Primary Induction Failure | Blood | Miriam Mozaffari Jovein Gabriele Ihorst Jesus Duque Afonso Ralph Wäsch Claudia Wehr | 2023/11/28 |
Patient‐derived xenograft mouse models to investigate tropism to the central nervous system and retina of primary and secondary central nervous system lymphoma | Neuropathology and Applied Neurobiology | Lisa Kristina Isbell Cordula Tschuch Soroush Doostkam Silvia Waldeck Geoffroy Andrieux | 2023/4 |
Early Prediction of Treatment Response By Circulating Tumor DNA Profiling in Patients with Diffuse Large B-Cell Lymphoma Receiving CAR T-Cell Therapy | Blood | Anna Katharina Foerster Corinna Kronenthaler Lavanya Ranganathan Samuel Bandara Corinna Woestmann | 2023/11/28 |
Additional file 1 of Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma | Julia Wendler Christopher P Fox Elke Valk Cora Steinheber Heidi Fricker | 2022 | |
The DKTK EXLIQUID consortium–exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients | Matthias Mack Julian Broche Stephen George Zahra Hajjari Florian Janke | 2022/8/26 | |
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer | Molecular oncology | Silvia Waldeck Jan Mitschke Sebastian Wiesemann Michael Rassner Geoffroy Andrieux | 2022/1 |
A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab-ozogamicin | Leukemia & Lymphoma | T Strüßmann R Wäsch F Scherer JA Mutter D Pfeifer | 2022/7/29 |
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation | Cancers | Miguel Waterhouse Sandra Pennisi Dietmar Pfeifer Florian Scherer Robert Zeiser | 2022/7/7 |
High-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients-a multicenter study by the cooperative PCNSL study group (MARTA study) | Blood | Elisabeth Schorb Lisa Isbell Andrea Kerkhoff Stephan Mathas Friederike Braulke | 2022/11/15 |
Co-Authors
